Baird raised the firm’s price target on Emerson (EMR) to $125 from $118 and keeps a Neutral rating on the shares. The firm said results modestly exceeded expectations with healthy margins and above-expected revenue levels.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
- Emerson price target raised to $135 from $128 at Wells Fargo
- Emerson price target raised to $116 from $103 at Barclays
- Emerson Electric Reports Strong 2024 Financial Results
- Aspen Technology confirms receipt of unsolicited takeover proposal from Emerson
- Emerson price target raised to $140 from $136 at Deutsche Bank